ELVN
Price
$22.25
Change
+$0.20 (+0.91%)
Updated
Jan 23, 03:55 PM (EDT)
Capitalization
1.08B
49 days until earnings call
PMCB
Price
$1.68
Change
+$0.02 (+1.20%)
Updated
Jan 23, 04:13 PM (EDT)
Capitalization
11.57M
54 days until earnings call
Ad is loading...

ELVN vs PMCB

Header iconELVN vs PMCB Comparison
Open Charts ELVN vs PMCBBanner chart's image
Enliven Therapeutics
Price$22.25
Change+$0.20 (+0.91%)
Volume$100
Capitalization1.08B
PharmaCyte Biotech
Price$1.68
Change+$0.02 (+1.20%)
Volume$400
Capitalization11.57M
ELVN vs PMCB Comparison Chart
Loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMCB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVN vs. PMCB commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a Hold and PMCB is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (ELVN: $22.05 vs. PMCB: $1.66)
Brand notoriety: ELVN and PMCB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 93% vs. PMCB: 45%
Market capitalization -- ELVN: $1.08B vs. PMCB: $11.57M
ELVN [@Biotechnology] is valued at $1.08B. PMCB’s [@Biotechnology] market capitalization is $11.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 0 FA rating(s) are green whilePMCB’s FA Score has 1 green FA rating(s).

  • ELVN’s FA Score: 0 green, 5 red.
  • PMCB’s FA Score: 1 green, 4 red.
According to our system of comparison, PMCB is a better buy in the long-term than ELVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 3 TA indicator(s) are bullish while PMCB’s TA Score has 4 bullish TA indicator(s).

  • ELVN’s TA Score: 3 bullish, 3 bearish.
  • PMCB’s TA Score: 4 bullish, 1 bearish.
According to our system of comparison, PMCB is a better buy in the short-term than ELVN.

Price Growth

ELVN (@Biotechnology) experienced а -2.69% price change this week, while PMCB (@Biotechnology) price change was +10.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.01%. For the same industry, the average monthly price growth was +3.24%, and the average quarterly price growth was -1.08%.

Reported Earning Dates

ELVN is expected to report earnings on May 08, 2025.

PMCB is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Biotechnology (+4.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($1.08B) has a higher market cap than PMCB($11.6M). PMCB YTD gains are higher at: 5.732 vs. ELVN (-2.000). PMCB has higher annual earnings (EBITDA): -5.41M vs. ELVN (-100.07M). ELVN has more cash in the bank: 292M vs. PMCB (20.8M). PMCB has less debt than ELVN: PMCB (75.2K) vs ELVN (85K). ELVN (0) and PMCB (0) have equivalent revenues.
ELVNPMCBELVN / PMCB
Capitalization1.08B11.6M9,284%
EBITDA-100.07M-5.41M1,850%
Gain YTD-2.0005.732-35%
P/E RatioN/A1.89-
Revenue00-
Total Cash292M20.8M1,404%
Total Debt85K75.2K113%
FUNDAMENTALS RATINGS
PMCB: Fundamental Ratings
PMCB
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
40
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
86
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELVNPMCB
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 16 days ago
89%
Bullish Trend 16 days ago
79%
Momentum
ODDS (%)
Bullish Trend 16 days ago
80%
Bullish Trend 16 days ago
73%
MACD
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 16 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 16 days ago
83%
Bullish Trend 16 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 16 days ago
86%
Bullish Trend 16 days ago
72%
Advances
ODDS (%)
Bullish Trend 21 days ago
83%
Bullish Trend 22 days ago
73%
Declines
ODDS (%)
Bearish Trend 17 days ago
89%
Bearish Trend 18 days ago
89%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 16 days ago
89%
N/A
View a ticker or compare two or three
Ad is loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMCB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBDIX121.560.27
+0.22%
Franklin Biotechnology Discovery A
ASCYX11.48N/A
N/A
Alger Small Cap Growth Y
PCSMX15.77-0.01
-0.06%
Principal SmallCap Growth I R6
TIBCX26.37-0.09
-0.34%
Thornburg Investment Income Builder C
PGJQX16.71-0.24
-1.42%
PGIM Jennison Global Infrastructure R6

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with CRNX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+0.23%
CRNX - ELVN
48%
Loosely correlated
-0.28%
OCEA - ELVN
48%
Loosely correlated
-3.12%
VYGR - ELVN
38%
Loosely correlated
+4.02%
ACLX - ELVN
38%
Loosely correlated
-1.08%
BPMC - ELVN
37%
Loosely correlated
-0.79%
More

PMCB and

Correlation & Price change

A.I.dvisor tells us that PMCB and FATE have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PMCB and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMCB
1D Price
Change %
PMCB100%
-0.60%
FATE - PMCB
33%
Poorly correlated
+1.52%
MBRX - PMCB
28%
Poorly correlated
-2.78%
BTAI - PMCB
28%
Poorly correlated
+1.54%
DTIL - PMCB
28%
Poorly correlated
+8.99%
ELVN - PMCB
27%
Poorly correlated
+0.23%
More